Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (41404)	11/14/2003 12:10:45 AM
From: Cogito Ergo Sum	Respond to of 74559

Hi Jay, Yes, sweet divi too. I have to see to getting out of just the NA markets. I'm seeing more and more limitations. Thanks for the motivation :o) regards Kastel

To: TobagoJack who wrote (41404)	11/14/2003 4:08:05 AM
From: energyplay	Read Replies (1) \| Respond to of 74559

Re: PPH Pharma Holdrs - From TheStreet.com - Adam Feuerstein Drugs on the Run 11/13/03 01:37 PM ET Drug stocks are rallying today. I've asked sources smarter than I for an explanation and I've received a variety of responses. "Very stupid people." "Rotation into the drugs in anticipation of higher interest rates, and a technical bottom." "Riding on Pfizer's coattails, plus rotation out of retails like WMT, TGT into more stable names." "Medicare reform is very close. Market looking for an excuse to rally these guys." none ******************** By the way, the news on Pfizer's Lipitor actually reducing EXISTING aterial plagck (instead of just slowing /stopping build up, which is what statins are expecte to do) is really good news for the whole industry. Add this to the new drug coated stents, new info on diets & exercise for cholesterol control, new info on apspirin and NSAIDS reducing inflamation, more powerful statistical informaiton on blood presure effects, the spread of automatic defrilbulators, early detection with C-reactive proteins - There is enough technology and information to make a massive reduction in heart attack rates - enough to effect life expectancy and possibly alter demographics.